The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
Open accessAbstract
Elucidating the risk of Parkinson's disease: High expression of the α-synuclein gene ( SNCA ) is a risk factor for Parkinson's disease (PD), but certain drugs may mitigate this risk. Mittal et al. ran a small-molecule screen to identify compounds that regulate levels of SNCA expression and found that several β2-adrenoreceptor (β2AR) agonists reduced them (see the Perspective by Snyder). These compounds modulated epigenetic marks at the SNCA gene, effectively suppressing SNCA transcription. The authors looked at the pharmaceutical history of more than 4 million Norwegians over an 11-year period and found a reduced risk of PD among those that were taking one of the β2AR agonists for other medical problems. Science , this issue p. 891 ; see also p. 869
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease
Zheng, B., Liao, Z., Locascio, J. J., Lesniak, K. A., Roderick, S. S., Watt, M. L., Eklund, A. C., Zhang-James, Y., Kim, P. D., Hauser, M. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001059 · Cited by 857
Self-citationα-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64553-1 · Cited by 714
Repression of α-synuclein expression and toxicity by microRNA-7
Junn, E., Lee, K.-W., Jeong, B. S., Chan, T. W., Im, J.-Y., & Mouradian, M. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906277106 · Cited by 655
α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease
Di Maio, R., Barrett, P. J., Hoffman, E. K., Barrett, C. W., Zharikov, A., Borah, A., Hu, X., McCoy, J., Chu, C. T., Burton, E. A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf3634 · Cited by 619
(2004) · doi:10.1002/ana.10846 · Cited by 614
Asthma: epidemiology, etiology and risk factors
Subbarao, P., Mandhane, P. J., & Sears, M. R. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.080612 · Cited by 550
Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons
Chung, C. Y., Khurana, V., Auluck, P. K., Tardiff, D. F., Mazzulli, J. R., Soldner, F., Baru, V., Lou, Y., Freyzon, Y., Cho, S., et al. (2013) · Science · doi:10.1126/science.1245296 · Cited by 441
Self-citationJowaed, A., Schmitt, I., Kaut, O., & Wüllner, U. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6119-09.2010 · Cited by 434
Pooled Analysis of Tobacco Use and Risk of Parkinson Disease
Ritz, B., Ascherio, A., Checkoway, H., Marder, K. S., Nelson, L. M., Rocca, W. A., Ross, G. W., Strickland, D., Van Den Eeden, S. K., & Gorell, J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.990 · Cited by 370
α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
Miller, D. W., Hague, S. M., Clarimon, J., Baptista, M., Gwinn-Hardy, K., Cookson, M. R., & Singleton, A. B. (2004) · Neurology · doi:10.1212/01.wnl.0000127517.33208.f4 · Cited by 356
Quantitative autoradiography of beta 1- and beta 2-adrenergic receptors in rat brain.
Rainbow, T. C., Parsons, B., & Wolfe, B. B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1585 · Cited by 351
Dettmer, U., Newman, A. J., Soldner, F., Luth, E. S., Kim, N. C., von Saucken, V. E., Sanderson, J. B., Jaenisch, R., Bartels, T., & Selkoe, D. (2015) · Nature Communications · doi:10.1038/ncomms8314 · Cited by 317
Self-citationInvolvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons
Mount, M. P., Lira, A., Grimes, D., Smith, P. D., Faucher, S., Slack, R., Anisman, H., Hayley, S., & Park, D. S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5321-06.2007 · Cited by 315
Self-citationIncidence of Parkinson's disease in Norway: the Norwegian ParkWest study
Alves, G., Muller, B., Herlofson, K., HogenEsch, I., Telstad, W., Aarsland, D., Tysnes, O.-B., Larsen, J. P., & for the Norwegian ParkWest study group (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.168211 · Cited by 273
GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein
Scherzer, C. R., Grass, J. A., Liao, Z., Pepivani, I., Zheng, B., Eklund, A. C., Ney, P. A., Ng, J., McGoldrick, M., Mollenhauer, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802437105 · Cited by 270
Self-citationTakahashi, H., Lassmann, T., Murata, M., & Carninci, P. (2012) · Nature Protocols · doi:10.1038/nprot.2012.005 · Cited by 264
Epigenetic modulation of the renal β-adrenergic–WNK4 pathway in salt-sensitive hypertension
Mu, S., Shimosawa, T., Ogura, S., Wang, H., Uetake, Y., Kawakami-Mori, F., Marumo, T., Yatomi, Y., Geller, D. S., Tanaka, H., et al. (2011) · Nature Medicine · doi:10.1038/nm.2337 · Cited by 236
Leng, Y., & Chuang, D.-M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0096-06.2006 · Cited by 188
Li, Q., Wu, H., Chen, S., Zhang, D., Ali, S. F., Peterson, L. J., Wilson, B. C., Lu, R., Hong, J., & Flood, P. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002449 · Cited by 123
Flierl, A., Oliveira, L. M. A., Falomir‐Lockhart, L. J., Mak, S. K., Hesley, J., Soldner, F., Arndt‐Jovin, D. J., Jaenisch, R., Langston, J. W., Jovin, T. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112413 · Cited by 88
Self-citationCarbone, M., Duty, S., & Rattray, M. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-38 · Cited by 64
Gleeson, L. C., Ryan, K. J., Griffin, É. W., Connor, T. J., & Harkin, A. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.06.015 · Cited by 60
A novel pathway for transcriptional regulation of α‐synuclein
Clough, R. L., & Stefanis, L. (2006) · The FASEB Journal · doi:10.1096/fj.06-7111com · Cited by 58
Genetic variability in SNCA and Parkinson’s disease
Pihlstrøm, L., & Toft, M. (2011) · Neurogenetics · doi:10.1007/s10048-011-0292-7 · Cited by 45
Hasegawa, E., Kang, D., Sakamoto, K., Mitsumoto, A., Nagano, T., Minakami, S., & Takeshige, K. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.9726 · Cited by 42
Lund, M. (2015) · BioMed Research International · doi:10.1155/2015/835080 · Cited by 30
Pharmacological Characterization of the Discriminative Stimulus Effects of Clenbuterol in Rats
O’Donnell, J. J. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00038-5 · Cited by 20
Cited by
Balestrino, R., & Schapira, A. H. V. (2020) · European Journal of Neurology · doi:10.1111/ene.14108 · Cited by 1,508
Update of the MDS research criteria for prodromal Parkinson's disease
Heinzel, S., Berg, D., Gasser, T., Chen, H., Yao, C., Postuma, R. B., & the MDS Task Force on the Definition of Parkinson's Disease (2019) · Movement Disorders · doi:10.1002/mds.27802 · Cited by 768
Progress towards therapies for disease modification in Parkinson's disease
Vijiaratnam, N., Simuni, T., Bandmann, O., Morris, H. R., & Foltynie, T. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00061-2 · Cited by 419
Lang, A. E., & Espay, A. J. (2018) · Movement Disorders · doi:10.1002/mds.27360 · Cited by 370
Phenotypic drug discovery: recent successes, lessons learned and new directions
Vincent, F., Nueda, A., Lee, J., Schenone, M., Prunotto, M., & Mercola, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00472-w · Cited by 348
Metadata
- Authors
- Mittal, S., Bjørnevik, K., Im, D. S., Flierl, A., Dong, X., Locascio, J. J., Abo, K. M., Long, E., Jin, M., Xu, B., Xiang, Y. K., Rochet, J.-C., Engeland, A., Rizzu, P., Heutink, P., Bartels, T., Selkoe, D. J., Caldarone, B. J., Glicksman, M. A., Khurana, V., Schüle, B., Park, D. S., Riise, T., & Scherzer, C. R.
- Venue
- Science
- Published
- 2017-09
- Volume
- 357
- Issue
- 6354
- Pages
- 891-898
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2753292637
- Cited by
- 416
- References
- 34
- FWCI
- 30.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.